Holen Sie sich die Stockscreener-App
4.26
11.80%
-0.57
Armata Pharmaceuticals Inc Aktie (ARMP) Neueste Nachrichten
Armata Pharmaceuticals, Inc.(NYSEAM:ARMP) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM: ARMP) added to Russell 2500 Growth Benchmark - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM: ARMP) added to Russell 2000 Index - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM:ARMP) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM: ARMP) added to Russell 3000E Growth Benchmark - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM: ARMP) added to Russell 3000E Index - marketscreener.com
Armata Pharmaceuticals, Inc.(NYSEAM:ARMP) added to Russell Small Cap Completeness Index - marketscreener.com
Enterprise value to EBITDA forward of Armata Pharmaceuticals, Inc. – AMEX:ARMP - TradingView
Armata Pharmaceuticals, Inc.(NYSEAM: ARMP) added to Russell 3000 Growth Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Armata Pharmaceuticals, Inc. – DUS:TG1N - TradingView
Price to earnings forward of Armata Pharmaceuticals, Inc. – AMEX:ARMP - TradingView
Price to earnings forward of Armata Pharmaceuticals, Inc. – DUS:TG1N - TradingView
Price to book forward of Armata Pharmaceuticals, Inc. – AMEX:ARMP - TradingView
Enterprise value to EBIT forward of Armata Pharmaceuticals, Inc. – DUS:TG1N - TradingView
Price to sales forward of Armata Pharmaceuticals, Inc. – AMEX:ARMP - TradingView
Price to book forward of Armata Pharmaceuticals, Inc. – BOATS:ARMP - TradingView
Enterprise value to revenue forward of Armata Pharmaceuticals, Inc. – AMEX:ARMP - TradingView
Enterprise value to EBITDA forward of Armata Pharmaceuticals, Inc. – BOATS:ARMP - TradingView
ARMATA PHARMACEUTICALS INC (ARMP) Stock Chart - ChartMill
ARMP Forecast — Price Target — Prediction for 2027 - TradingView
Armata Pharmaceuticals, Inc. Actuals & Estimates (DUS:TG1N) - TradingView
Armata Pharmaceuticals, Inc. Actuals & Estimates (MUN:TG1N) - TradingView
TG1N Forecast — Price Target — Prediction for 2027 - TradingView
Armata Pharmaceuticals, Inc. Appoints Daniel Gilmer to Serve on the Nominating and Corporate Governance Committee of the Board, Effective as of June 24, 2026 - marketscreener.com
Armata Pharmaceuticals Inc. (ARMP) Climbs 4.85%, Testing Resistance at $7.72Trend Reversal Picks - dars.gov.et
Armata Pharmaceuticals (ARMP) assigns Gilmer to governance committee with $5,000 retainer - Stock Titan
Armata Pharmaceuticals (ARMP) Secures $2.5M for Clinical Development - GuruFocus
Armata Pharmaceuticals stock jumps on added DoD funding - Investing.com
Form 8K Armata Pharmaceuticals Inc For: 23 June By Investing.com - Investing.com Australia
Armata receives $2.5m DoD funding for AP-SA02 development - Investing.com UK
Armata receives $2.5m DoD funding for AP-SA02 development By Investing.com - Investing.com India
Armata Pharmaceuticals Shares Rise on Additional $2.5M Government Grant - Moomoo
Armata Pharmaceuticals stock jumps on added DoD funding By Investing.com - Investing.com South Africa
Armata Pharmaceuticals Receives Additional $2.5 Million in Funding From US Department of Defense - Moomoo
Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02 - The AI Journal
Armata Pharmaceuticals Shares Rise on Additional $2.5 Million Government Grant - marketscreener.com
Armata gains new DoD funding for AP-SA02 advancement - TipRanks
Armata Pharmaceuticals Secures Additional $2.5M DoD Funding to Advance Phase 3 Phage Therapy for MRSA Infections 1 - Minichart
Armata Pharmaceuticals Inc (ARMP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Armata Pharmaceuticals Granted FDA Fast Track Designation for AP-SA02 - HarianBasis.co
Here’s Why Armata Pharmaceuticals Inc. (ARMP) is a High Growth Micro-Cap Stock to Buy? - Insider Monkey
Armata Pharmaceuticals Inc (ARMP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Armata Pharmaceuticals Inc (ARMP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Armata Pharmaceuticals Inc - TradingKey
Armata Pharmaceuticals Inc (ARMP) Institutional Confidence - TradingKey
Armata Pharmaceuticals Inc (ARMP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Armata Pharmaceuticals Inc (ARMP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Armata Pharmaceuticals Inc (ARMP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Armata Pharmaceuticals, Inc. Financial Disclosures & SEC Filings - TradingView
Armata Pharmaceuticals (ARMP) Q1 2026 Earnings: Massive EPS Miss as Pre-Revenue Biotech Faces Cost Pressures - dars.gov.et
Armata Pharmaceuticals shareholders elect board and approve executive pay at annual meeting - Investing.com Canada
Armata Pharmaceuticals shareholders elect board and approve executive pay at annual meeting By Investing.com - Investing.com South Africa
Armata Shareholders Approve Directors, Executive Pay and Auditor - TipRanks
Armata (NYSE: ARMP) investors approve board, pay plan and 2026 auditor - Stock Titan
Armata Pharmaceuticals (ARMP) Edges Lower Amid Sector Pressure – Key Levels in FocusPost-Earnings Moves - newsline.com
2.64%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):